iShares China Large-Cap ETF vs Monster Beverage Corp — how do they compare? iShares China Large-Cap ETF trades at $34.25 (market cap $3.86B), while Monster Beverage Corp trades at $43.64 (market cap $85.51B). The key difference: Monster Beverage Corp is far larger — about 22.2× iShares China Large-Cap ETF's market cap, and Monster Beverage Corp is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 150 Days and Monster Beverage Corp for 72 Days on average.
| FXI | MNST | |
|---|---|---|
Market Cap | $3.86B | $85.51B |
Volume | 16,323,837 | 8,569,709 |
52-Week High | $41.08 | $49.97 |
52-Week Low | $31.59 | $33.16 |
Typical Hold Time | 150 Days | 72 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | $83.81B |
Signals from Pluang's Aura AI — not financial advice
FXI trades at $33.45 with minimal daily movement (+0.09%), reflecting subdued momentum amid bearish technical signals. The ETF faces significant technical headwinds with 17 sell signals versus 1 buy, though oscillators remain neutral. Recent news highlights China's mixed economic signals, including strong export growth but persistent overcapacity concerns. The Trump-Xi summit in September 2026 offered limited progress on trade tensions, maintaining geopolitical uncertainty for Chinese equities.
FXI presents a value opportunity with a P/E ratio of 11.10—half the S&P 500's valuation—and a 1.98% yield, but faces substantial risks from China's economic rebalancing, weak domestic consumption, and potential export controls. Investor sentiment is cautious due to political and macroeconomic headwinds, though some analysts see long-term potential if China stabilizes growth.
Monster Beverage (MNST) trades at $43.65, up 1.8% with bullish technical signals and strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $0.30 exceeding expectations. Revenue grew to $8.29B in 2025 with impressive 23.08% net margins and zero long-term debt. Recent 1:2 stock split on August 11, 2026, enhances accessibility while international sales surge 35% in Q2 2026.
MNST presents growth potential through international expansion and clean balance sheet, but faces valuation concerns with P/E of 40.42. Analyst consensus targets $98.22 (52% buy ratings) suggesting significant upside. Key risks include regulatory challenges in markets like India and competitive pressure from beverage giants. The stock's premium valuation requires sustained high growth to justify current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →